Helicobacter Pylori Diagnostics Market share, Size, trends and industry Analysis
Helicobacter Pylori Diagnostics Helicobacter is a spiral-shaped gram-negative bacterium that causes ulcers in the stomach and duodenum by producing persistent inflammation and infection. H. pylori is identified in 50-80 percent of gastric ulcer patients and 90 percent of duodenal ulcer patients. Peptic ulcer disease is likely to develop in one out of every six people infected with H. pylori. Infected people have long-term asymptomatic problems, with over 70% of them experiencing minor symptoms including belching, bloating, nausea, vomiting, and stomach discomfort on a regular basis, whilst significant symptoms include abdominal pain, peptic ulcers, and foul breath. Invasive tests, which need stomach mucosa samples collected by endoscopy and utilised for biopsy, or non-invasive testing, which require blood or stool samples, can be used to identify Helicobacter infection. The global Helicobacter Pylori Diagnostics Market size was valued at US$ 437.3 million in 2017 and is expected t